Staff Profile
Professor Adam Todd
Professor of Pharmaceutical Public Health
- Telephone: +44 (0) 191 208 2355
Adam Todd is a Professor of Pharmaceutical Public Health, and Deputy Head of the School of Pharmacy at Newcastle University. He is a qualified pharmacist registered with the General Pharmaceutical Council, and a Fellow of the Royal Pharmaceutical Society of Great Britain. He was previously a Senior Lecturer at Durham University where he held the roles of MPharm Programme Director, Director of Education, and Deputy Director of the Centre of Health and Inequalities Research (CHIR). He was awarded a Readership in 2017, and a personal Chair in 2021.
His research is highly interdisciplinary, and uses methods from the social sciences, public health, clinical medicine, and epidemiology. He leads a programme of research that applies pharmaceutical knowledge to prevent disease, prolong life, promote health, and reduce health inequalities, across different populations. His research outputs have had considerable impact on policy and practice.
Adam has a number of international research collaborations across Europe, the United States and Australia. He is a member of CHAIN, the Centre of Global Health Inequalities Research – a leading international research centre that seeks to monitor, explain, and reduce inequalities in health. He is also a steering group member of the English Deprescribing Network (EDeN) – a network established to reduce inappropriate and problematic polypharmacy through deprescribing.
He has experience of serving on national research committees, and has previously contributed to the NIHR Research for Patient Benefit Committee for the Yorkshire & North East region; he is currently a member of the NIHR HTA Prioritisation Committee for community health and social care. Adam also chairs the Scientific Advisory Panel for Pharmacy Research UK - the principal research charity supporting pharmacy to improve healthcare for the benefit of patients and the public.
Adam has total career research funding of over £15 million, including funding from the NIHR, Macmillan Cancer Research, the Barbour Foundation, and the Sir Bobby Robson Foundation. Adam reviews for more than 30 international peer reviewed journals, serves on a number of journal editorial boards, and has published more than 100 peer-reviewed research articles, as well as an international patent.
In addition to his research activities, Adam is also actively involved in delivering the MPharm Programme at Newcastle; he approaches pharmacy education in an integrated way, and combines both science and practice elements in his teaching. Using this integrated approach, Adam has published two international books focusing on antibacterial and anticancer therapeutics. He is a Senior Fellow of the Higher Education Academy, and has previously served as academic member of the General Pharmaceutical Council Accreditation and Recognition Panel.
Adam still contributes to the care of patients on a regular basis; he works alongside the specialist palliative care Multidisciplinary Team at St. Benedict’s Hospice, providing guidance on (de)prescribing; he also regularly works as a community pharmacist delivering public health interventions to the local community.
Adam is involved in a range regional, national, and international multidisciplinary projects focusing on pharmaceutical public health and health inequalities.
Current PhD students:
Rayah Asiri (funded by the government of the Kingdom of Saudi Arabia) who is exploring the challenges of medication adherence in minority ethnic communities
Janine Beezer (supported by The British Society for Heart Failure) who is examining the relationships between polypharmacy and adverse outcomes in people with heart failure
Nathania Bestwick (funded through the NIHR PSRC) who is examining inequalities in multiple long term conditions for people with cancer
Dr. Maguy El Hajj (self-funded) who is investigating the challenges of delivering medication safety initiatives in community pharmacy settings
Katie Elliott (funded through The Barbour Foundation) who is investigating the relationship between mental health condition and treatment receipt amongst older people with cancer
Hilary Shepherd Holding (funded through The Dunhill Medical Trust) who is exploring the interplay between multimorbidity and polypharmacy amongst older people
Anum Iqbal (supported by the NIHR ARC NENC) who is exploring socioeconomic inequalities in polypharmacy amongst older people
Tania Jones (supported by the School of Pharmacy) who is developing and evaluating a novel opioid deprescribing intervention in primary care
Radin Karimi (funded through the NIHR PSRC) who is examining polypharmacy and medication safety in people using Home Care services
Amber Sacre (funded through the NIHR ARC NENC) who is exploring socioeconomic inequalities in vaccination
Emily Shaw (funded through the NIHR PSRC) who is examining inequalities in outcomes for people using immuno-, biological, and precision therapies.
Rajeev Shrestha (funded through the NIHR PSRC) who is examining polypharmacy and patient safety challenging for people using palliative and end of life care services.
Adam is a passionate educator and teacher, and has contributed to the development of a number of innovative pharmacy programmes in the UK. He strongly believes that an integrated approach to pharmacy education – combining both science and practice elements – is the cornerstone to a successful MPharm degree.
He has extensive experience of developing new programmes, and was part of the team at Durham University that developed a highly innovative MPharm degree programme, which gained full accreditation with the General Pharmaceutical Council (the independent regulator for pharmacy education in the UK) without any conditions or recommendations. Adam has been external examiner at a number of different Schools of Pharmacy, as well as an academic member of the General Pharmaceutical Council Accreditation and Recognition Panel.
He has occupied a range of leadership positions in higher education, including Module Leader, Year Leader, Programme Director and Chair of Education Committee. He also has experience of developing work-based learning within an MPharm degree, and was one of the first that attempted to embed students in different communities of practice where they undertake genuine peripheral participation within clinical environments.
Adam has an important role in teaching the MPharm degree at Newcastle, and contributes to a number of stages and modules. His teaching is regularly recognised by students as some of the best in the University. In recent years, he has developed a series of small case-based integration sessions that allow students to contextualise their learning and apply key concepts of science to solve simple clinical problems often encountered by patients.
-
Articles
- McInerney BE, Cross AJ, Alderman CP, Bhat R, Boyd CM, Brandt N, Cossette B, Desforges K, Dowd LA, Frank C, Hartikainen S, Herrmann N, Hilmer SN, Jack L, Jordan S, Kitamura CR, Koujiya E, Lampela P, Macfarlane S, Manias E, Martin C, Martinez-Velilla N, Moriarty F, Onder G, Quirke T, Silvius JL, Soulsby N, Stafford AC, Steinman MA, Sun W, Taguchi R, Todd A, Trenaman SC, Yap KZ, Zhao M, Bell JS, Turner JP. Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities. Journal of the American Medical Directors Association 2024, 25(9), 105118.
- Davies LE, Spiers GF, Kingston A, Todd A, Hanratty B. The Co-Occurrence of Polypharmacy and Unmet Needs for Social Care in Older People: A Systematic Review. Health and Social Care in the Community 2024, 2024, 9849110.
- Norris RP, Dew R, Greystoke A, Cresti N, Cain H, Todd A, Sharp L. Sociodemographic Disparities in HER2+ Breast Cancer Trastuzumab Receipt: An English Population-Based Study. CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION 2024, 33(10), 1298-1310.
- Todd A, Waldron C, McGeagh L, Norris R, Bolnykh I, Stewart SJ, Slodkowska-Barabasz J, Moon Z, Cahir C, Thompson S, Harmer V, Wells M, Watson E, Sharp L. Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: a systematic review of reviews. Cancer Medicine 2024, 13(3), e6937.
- Simkins J, Holden MA, Babatunde O, White S, Nicholls E, Long A, Dziedzic K, Chudyk A, Todd A, Walker C, Stanford C, Cottrell E, Edwards J, Healey EL, Cork T, Mallen C, OBrien N. Exploring the potential extended role of community pharmacy in the management of osteoarthritis: A multi-methods study with pharmacy staff and other healthcare professionals. Musculoskeletal Care 2024, 22(1), e1873.
- Weir KR, Vordenberg SE, Scherer AM, Jansen J, Schoenborn N, Todd A. Exploring Different Contexts of Statin Deprescribing: A Vignette-Based Experiment with Older Adults Across Four Countries. Journal of General Internal Medicine 2024, Epub ahead of print.
- Chua S, Todd A, Reeve E, Smith SM, Fox J, Elsisi Z, Hughes S, Husband A, Langford A, Merriman N, Harris JR, Devine B, Gray SL. Deprescribing Interventions in Older Adults: An Overview of Systematic Reviews. PLoS ONE 2024, 19(6), e0305215.
- Babatunde OO, Cottrell E, White S, Chudyk A, Healey EL, Edwards J, Nicholls E, O'Brien N, Todd A, Walker C, Stanford C, Cork T, Long A, Simkins J, Mallen CD, Dziedzic K, Holden MA. Co-development and testing of an extended community pharmacy model of service delivery for managing osteoarthritis: protocol for a sequential, multi-methods study (PharmOA). BMC Musculoskeletal Disorders 2024, 25(1), 54.
- Elliott K, Haworth E, Bolnykh I, McAllister-Williams HR, Greystoke A, Todd A, Sharp L. Breast cancer patients with a pre-existing mental illness are less likely to receive guideline-recommended cancer treatment: a systematic review and meta-analysis. The Breast 2024, Epub ahead of print.
- Todd A, Hanratty B. Beyond polypharmacy to the brave new world of minimum datasets and artificial intelligence: thumbing a nose to Henry. BMJ Quality & Safety 2024, Epub ahead of print.
- Wilkinson C, Moloney S, McClelland G, Todd A, Doran T, Price C. Actioning atrial fibrillation identified by ambulance services in England: a qualitative exploration. BMJ Open 2024, 14, e078777.
- Crowe L, Brown M, Lecouturier J, Greystoke A, Bojke A, Bojke R, Richardson J, Wells M, Ezeala E, Carter L, Sharp L, Todd A. “Oh when’s your treatment ending?” “Never!” The unmet needs of cancer patients treated with immuno-, biological and precision therapies: a qualitative interview study. European Journal of Oncology Nursing 2024, 73, 102696.
- Robinson-Barella A, Richardson CL, Bayley Z, Husband A, Bojke A, Bojke R, Exley C, Hanratty B, Elverson J, Jansen J, Todd A. “Starting to think that way from the start”: approaching deprescribing decision-making for people accessing palliative care - a qualitative exploration of healthcare professionals views. BMC Palliative Care 2024, 23, 221.
- Asiri R, Robinson-Barella A, Iqbal A, Todd A, Husband A. Understanding the influence of ethnicity on adherence to antidiabetic medication: Meta-ethnography and systematic review. PLoS One 2023, 18(10), e0292581.
- Brevik TB, Calegari LRM, Metcalfe IM, Laake P, Maza M, Basu P, Todd A, Carvalho AL. Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components. BMC Medical Education 2023, 23, 712.
- Richardson CL, Saeed M, Sharp L, Todd A. The association between marital status and treatment initiation in lung cancer: A systematic review and meta-analysis of observational studies. Cancer Epidemiology 2023, 87, 102494.
- Sacre A, Bambra C, Wildman JM, Thomson K, Bennett N, Sowden S, Todd A. Socioeconomic inequalities in vaccine uptake: A global umbrella review. PLoS ONE 2023, 18, e0294688.
- Norris RP, Dew R, Greystoke A, Todd A, Sharp L. Socio-economic Inequalities in Novel NSCLC Treatments During the Era of Tumor Biomarker Guided Therapy: A Population-based Cohort Study in a Publicly Funded Healthcare System. Journal of Thoracic Oncology 2023, 18(8), 990-1002.
- Sturrock A, Bissett SM, Carrozzo M, Lish R, Howe D, Mountain S, Nugent M, O'Hara J, Preshaw PM, Todd A, Wilkes S. Qualitative interview study exploring the early identification and referral of patients with suspected head and neck cancer by community pharmacists in England. BMJ open 2023, 13(3), e068607.
- Bissett SM, Sturrock A, Carrozzo M, Lish R, Howe D, Mountain S, Nugent M, O'Hara J, Todd A, Wilkes S, Preshaw PM. Is the early identification and referral of suspected head and neck cancers by community pharmacists feasible? A qualitative interview study exploring the views of patients in North East England. Health Expectations 2023, 26(5), 2089-2097.
- Davies LE, Todd A, Sinclair D, Robinson L, Kingston A. Is polypharmacy associated with difficulty taking medicines in people aged ≥85 living at home? Findings from the Newcastle 85+ Study. British Journal of Clinical Pharmacology 2023, 89(10), 3217-3227.
- Vordenberg SE, Weir KR, Jansen J, Todd A, Schoenborn N, Scherer AM. Harm and medication-type impact agreement with hypothetical deprescribing recommendations: A vignette-based experiment with older adults across four countries. Journal of General Internal Medicine 2023, 38, 1439-1448.
- Asiri R, Todd A, Robinson-Barella A, Husband A. Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence. PLoS ONE 2023, 18(2), e0271650.
- McCann J, Lau WM, Husband A, Todd A, Sile L, Doll AK, Varia S, Robinson-Barella A. 'Creating a culturally competent pharmacy profession': A qualitative exploration of pharmacy staff perspectives of cultural competence and its training in community pharmacy settings. Health Expectations 2023, 26(5), 1941-1953.
- Crowe L, Brown M, Bojke A, Bojke R, Greystoke A, Lecouturier J, Richardson J, Wells M, Todd A, Sharp L. Assessing the unmet needs of patients with advanced cancer treated by biological and precision therapies: protocol for TARGET, a mixed methods study. BMJ Open 2023, 13, e066229.
- Iqbal A, Richardson C, Iqbal Z, O'Keefe H, Hanratty B, Matthews FE, Todd A. Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis. BMC Geriatrics 2023, 23(1), 149.
- Adamson J, Hanson H, Todd A, Duncan R, Hanratty B, Robinson L. "No trouble at all" - medication work amongst nonagenarians: a qualitative study of the Newcastle 85+ cohort participants at 97. British Journal of General Practice 2023, 73(729), e267-e275.
- Rahman S, Trussell A, Pearson SA, Buckley NA, Karanges EA, Cairns R, Litchfield M, Todd A, Gisev N. Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003 to 2015). Drug and Alcohol Review 2022, 41(2), 435-443.
- Bingpong K, Thomson K, McNamara CL, Besnier E, Balaj M, Ahkter N, Bambra C, Todd A. The Gender Pain Gap: The gender gap in pain in 19 European countries. Scandinavian Journal of Public Health 2022, 50(2), 287-294.
- Chew-Graham CA, Kitchen CEW, Gascoyne S, Littlewood E, Coleman E, Bailey D, Crosland S, Pearson C, Ali S, Badenhorst J, Bambra C, Hewitt C, Jones C, Keding A, McMillan D, Sloan C, Todd A, Toner P, Whittlesea C, Watson M, Gilbody S, Ekers D. The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation—the Community Pharmacies Mood Intervention Study (CHEMIST). Pilot and Feasibility Studies 2022, 8(1), 27.
- Welford J, Rafferty R, Hunt K, Short D, Duncan L, Ward A, Rushton C, Todd A, Nair S, Hoather T, Clarke M, Dawes L, Dawson F, Anderson V, Pelham A, Lowe H, Dewhurst F, Greystoke A. The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato-oncology inpatients: A cohort study. European Journal of Cancer Care 2022, 31(6), e13752.
- Sacre A, Bambra C, Wildman JM, Thomson K, Sowden S, Todd A. Socioeconomic Inequalities and Vaccine Uptake: An Umbrella Review Protocol. International Journal of Environmental Research and Public Health 2022, 19(18), 11172.
- Robinson A, O'Brien N, Sile L, Guraya HK, Govind T, Harris V, Pilkington G, Todd A, Husband A. Recommendations for community pharmacy to improve access to medication advice for people from ethnic minority communities: a qualitative person-centred co-design study. Health Expectations 2022, 25(6), 3040-3052.
- Davies L, Kingston A, Todd A, Hanratty B. Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ Study. International Journal of Clinical Pharmacy 2022, 44, 1072-1077.
- Scullion L, Dodds H, Liu Q, Hunt ME, Gordon S, Todd A. Medication use in the last year of life: a cross sectional hospice study. BMJ Supportive & Palliative Care 2022, 12(e6), e740-e743.
- Davies LE, Kingston A, Todd A, Hanratty B. Is polypharmacy associated with mortality in the very old: findings from the Newcastle 85+ Study. British Journal of Clinical Pharmacology 2022, 88(6), 2988-2995.
- O'Neil H, Todd A, Pearce M, Husband A. Investigating the relationship between harm and over or under-treatment of frail patients living with diabetes, admitted to hospital. . Practical Diabetes 2022, 39(3), 23-26a.
- Richardson CL, Rook L, Pearson E, Mundell A, Todd A. Identification and evaluation of medication-related issues relating to patient’s own drugs by pharmacy students while on placement in a tertiary hospital. International Journal of Clinical Pharmacy 2022, 44, 575-579.
- Iqbal A, Matthews F, Hanratty B, Todd A. How should a physician assess medication burden and polypharmacy?. Expert Opinion On Pharmacotherapy 2022, 23(1), 1-4.
- Davies L, Kingston A, Todd A, Robinson L. Does polypharmacy shape dependency transitions in the very old? Findings from the Newcastle 85+ Study . Age and Ageing 2022, 51(10).
- Kerrison R, Robinson A, Skrobanski H, Kayal G, Kaushal A, Ide-Walters C, Todd A, Husband A, Lakhani S, Alter M, von Wagner C, MacDonald L. Demographic and psychological predictors of community pharmacists' cancer-related conversations with patients: a cross-sectional analysis and survey study. BMC Health Services Research 2022, 22, 268.
- Rimmer B, Crowe L, Todd A, Sharp L. Assessing unmet needs in advanced cancer patients: a systematic review of the development, content, and quality of available instruments. Journal of Cancer Survivorship 2022, 16, 960-975.
- Robinson A, Elarbi M, Todd A, Husband A. A qualitative exploration of the barriers and facilitators affecting ethnic minority patient groups when accessing medicine review services: Perspectives of healthcare professionals. Health Expectations 2022, 25(2), 628-638.
- Littlewood E, Chew-Graham CA, Coleman E, Gascoyne S, Sloan C, Ali S, Badenhorst J, Bailey D, Crosland S, Kitchen CEW, McMillan D, Pearson C, Todd A, Whittlesea C, Bambra C, Hewitt C, Jones C, Keding A, Newbronner E, Paterson A, Rhodes S, Ryde E, Toner P, Watson M, Gilbody S, Ekers D. A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT. Public Health Research 2022, 10(5).
- Robinson A, Sile L, Govind T, Guraya HK, O'Brien N, Harris V, Pilkington G, Todd A, Husband A. "He or she maybe doesn’t know there is such a thing as a review": a qualitative investigation exploring barriers and facilitators to accessing medication reviews from the perspective of people from ethnic minority communities. Health Expectations 2022, 25(4), 1432-1443.
- Besnier E, Thomson K, Stonkute D, Mohammad T, Akhter N, Todd A, Rom Jensen M, Kilvik A, Bambra C. Which public health interventions are effective in reducing morbidity, mortality and health inequalities from infectious diseases amongst children in low- and middle-income countries (LMICs): an umbrella review. PLoS ONE 2021, 16(6), e0251905.
- Tervonen HE, Schaffer AL, Luckett T, Phillips J, Litchfield M, Todd A, Pearson SA. Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia. Pharmacoepidemiology and Drug Safety 2021, 30(3), 360-370.
- Todd A, Bambra C. Learning from past mistakes? The COVID-19 Vaccine and the Inverse Equity Hypothesis. European Journal of Public Health 2021, 31(1).
- Davies LE, Kingston A, Todd A, Hanratty B. Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study. PLoS ONE 2021, 16(1), e0245648.
- Rathbone AP, Jamie K, Todd A, Husband A. A qualitative study exploring the lived experience of medication use in different disease states: linking the experiences of disease symptoms to medication adherence. Journal of Clinical Pharmacy and Therapeutics 2021, 46(2), 352-362.
- Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, Hopper I, Hilmer SN, Gnjidic D. Withdrawal of antihypertensive drugs in older people. Cochrane Database of Systematic Reviews 2020, (6), CD012572.
- Norris R, Dew R, Sharp L, Greystoke A, Rice S, Johnell K, Todd A. Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis. BMC Medicine 2020, 18, 282.
- Thomson K, Berry R, Robinson T, Brown H, Bambra C, Todd A. An examination of trends in antibiotic prescribing in primary care and the association with area-level deprivation in England. BMC Public Health 2020, 20, 1148.
- Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. Journal of the American Medical Directors Association (JAMDA) 2020, 21(2), 181–187.
- Sawan M, Reeve E, Turner J, Todd A, Steinman MA, Petrovic M, Gnjidic D. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health care settings and countries: a narrative review. Expert Review of Clinical Pharmacology 2020, 13(3), 233-245.
- Nazar H, Evans C, Kyei N, Lindsey L, Nazar Z, Thomson K, Yeung A, Todd A. A service evaluation and stakeholder perspectives of an innovative digital minor illness referral service from NHS 111 to community pharmacy. PLoS ONE 2020, 15(3), e0230343.
- Besnier E, Thomson K, Stonkute D, Mohammad T, Akhter N, Todd A, Jensen MR, Kilvik A, Bambra C. Which public health interventions are effective in reducing morbidity, mortality and health inequalities from infectious diseases amongst children in low- and middle-income countries (LMICs): protocol for an umbrella review. BMJ Open 2019, 9(12), e032981.
- Nazar H, Lindsey L, Fletcher J, Rook L, Todd A, Husband A. Training Student Pharmacists in Medication Dispensing and Checking Within a High-Fidelity Clinical Environment. American Journal of Pharmaceutical Education 2019, 83(7), 7106.
- Todd A, McNamara CL, Balaj M, Huijts T, Akhter N, Thomson K, Kasim A, Eikemo TA, Bambra C. The European epidemic: Pain prevalence and socioeconomic inequalities in pain across 19 European countries. European Journal of Pain 2019, 23(8), 1425-1436.
- Thomson K, Hillier-Brown F, Walton N, Bilaj M, Bambra C, Todd A. The effects of community pharmacy delivered public health interventions on population health and health inequalities: a review of reviews. Preventive Medicine 2019, 124, 98-109.
- Smith D, Thomson K, Bambra C, Todd A. The breast cancer paradox: a systematic review of the association between area-level deprivation and breast cancer screening uptake in Europe. Cancer Epidemiology 2019, 60, 77-85.
- Morin L, Todd A, Barclay S, Wastesson JW, Fastbom J, Johnell K. Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?. Cancer 2019, 125(13), 2309-2317.
- Sampson SJ, Todd A, Walton N, Steele R, Webster L, Churchill R, McMillan D, Gilbody S, Ekers D. Pharmacy‐based management for depression in adults. Cochrane Database of Systematic Reviews 2019, (4), CD013299.
- Rathbone AP, Nazar H, Harburn J, Todd A, Husband A. Exploring Undergraduate Pharmacy Student Experiences of Learning Human Anatomy Using Cadaveric Specimens. American Journal of Pharmaceutical Education 2019, 83(8), 7103.
- Steed L, Sohanpal R, Todd A, Madurasinghe VM, Rivas C, Edwards EA, Summerbell CD, Taylor SJC, Walton RT. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews 2019, (12), CD011207.
- Littlewood E, Ali S, Badenhorst J, Bailey D, Bambra C, Chew-Graham C, Coleman E, Crosland S, Gascoyne S, Gilbody S, Hewitt C, Jones C, Keding A, Kitchen C, McMillan D, Pearson C, Rhodes S, Sloan C, Todd A, Watson M, Whittlesea C, Ekers D. Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocol. Pilot and Feasibility Studies 2019, 5, 71.
- Todd A, Akhter N, Cairns JM, Kasim A, Walton N, Ellison A, Chazot P, Eldabe S, Bambra C. The Pain Divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England. BMJ Open 2018, 8(7), e023391.
- Thomson K, Hillier-Brown F, McNamarra C, Todd A, Huijits T, Bambra C. The effects of public health policies on health inequalities in high-income countries: an umbrella review. BMC Public Health 2018, 18, 869.
- Todd A, Jansen J, Colvin J, McLachlan AJ. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatrics 2018, 18, 295.
- Todd A, Al-Khafaji J, Akhter N, Kasim A, Quibell R, Merriman K, Holmes H. Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life - an international cohort study. British Journal of Clinical Pharmacology 2018, 84(12), 2802-2810.
- Todd A, Thomson K, Kasim A, Bambra C. Cutting care clusters: the creation of an inverse pharmacy care law? An area level analysis exploring the clustering of community pharmacies in England. BMJ Open 2018, 8(7), e022109.
- Okeowo D, Patterson A, Boyd C, Reeve E, Gnjidic D, Todd A. Clinical practice guidelines for older people with multi-morbidity and life limiting illness: what are the implications for deprescribing?. Therapeutic Advances in Drug Safety 2018, 9(11), 619-630.
- Gnjidic D, Husband A, Todd A. Challenges and innovations of delivering medicines to older adults. Advanced Drug Delivery Reviews 2018, 135, 97-105.
- Hillier-Brown F, Bambra C, Thomson K, Balaj M, Walton N, Todd A. The effects of community pharmacy public health interventions on population health and health inequalities: a systematic review of reviews protocol. Systematic Reviews 2017, 6, 176.
- Todd A, Husband A, Andrew I, Pearson S, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Supportive & Palliative Care 2017, 7(2), 113-121.
- Lindsey L, Husband AK, Steed L, Walton R, Todd A. Helpful advice and hidden expertize: pharmacy users' experience of community pharmacy accessibility. Journal of Public Health 2017, 39(3), 609-615.
- Fjær EL, Balaj M, Stornes P, Todd A, McNamara CL, Eikemo TA. Exploring the differences in general practitioner and health care specialist utilization according to education, occupation, income and social networks across Europe: findings from the European social survey (2014) special module on the social determinants of health. European Journal of Public Health 2017, 27(suppl_1), 73-81.
- Steed L, Sohanpal R, James WY, Rivas C, Jumbe S, Chater A, Todd A, Edwards E, Macneil V, Macfarlane F, Greenhalgh T, Griffiths C, Eldridge S, Taylor S, Walton R. Equipping community pharmacy workers as agents for health behaviour change: developing and testing a theory-based smoking cessation intervention. BMJ Open 2017, 7, e015637.
- Thomson K, Bambra C, McNamara C, Huijits T, Todd A. The effects of public health policies on population health and health inequalities in European welfare states: protocol for an umbrella review. Systematic Reviews 2016, 5, 57.
- Todd A, Holmes H, Pearson S, Hughes C, Andrew I, Baker L, Husband A. 'I don't think I'd be frightened if the statins went': A phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals. BMC Palliative Care 2016, 15(1), 13.
- Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271.
- Brown TJ, Todd A, O'Malley CL, Moore HJ, Husband AK, Bambra C, Kasim A, Sniehotta FF, Steed L, Summerbell CD. Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions. Public Health Research 2016, 4(2), 1-155.
- Dewhurst F, Baker L, Andrew I, Todd A. Blood pressure evaluation and review of antihypertensive medication in patients with life limiting illness. International Journal of Clinical Pharmacy 2016, 38(5), 1044-1047.
- Badenhorst J, Todd A, Lindsey L, Ling J, Husband A. Widening the scope for early cancer detection: identification of alarm symptoms by community pharmacies. International Journal of Clinical Pharmacy 2015, 37(3), 465-470.
- Todd A, Holmes HM. Recommendations to support deprescribing medications late in life. International Journal of Clinical Pharmacy 2015, 37(5), 678-681.
- Lindsey L, Husband A, Nazar H, Todd A. Promoting the early detection of cancer: A systematic review of community pharmacy-based education and screening interventions. Cancer Epidemiology 2015, 39(5), 673-681.
- Firth H, Todd A, Bambra C. Benefits and barriers to the public health pharmacy: a qualitative exploration of providers’ and commissioners’ perceptions of the Healthy Living Pharmacy Framework. Perspectives in Public Health 2015, 135(5), 251-256.
- Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open 2015, 5(5), e007328.
- Nazar H, Nazar Z, Portlock J, Todd A, Slight SP. A systematic review of the role of community pharmacies in improving the transition from secondary to primary care. British Journal of Clinical Pharmacology 2015, 80(5), 936-948.
- Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014, 4(8), e005764.
- Todd A, Husband AK, Hurren A, Kler S, Ling J. Patients using antifungals following laryngectomy: A qualitative study of community pharmacists in the North of England. International Journal of Pharmacy Practice 2014, 22(3), 193-199.
- Todd A, Nazar H, Pearson S, Andrew I, Baker L, Husband A. Inappropriate prescribing in patients accessing specialist palliative day care services. International Journal of Clinical Pharmacy 2014, 36(3), 535-543.
- Todd A, Moore H, Husband A, Bambra C, Kasim A, Sniehotta F, Steed L, Summerbell C. Community pharmacy interventions for public health priorities: protocol for a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions. Systematic Reviews 2014, 3, 93.
- Steed L, Kassavou A, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, Nkansah N, Bero L, Durieux P, Taylor SJC, Rivas C, Walton RT. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes. Cochrane Database of Systematic Reviews 2014, (7), CD011207.
- Todd A, Husband AK, Richardson R, Jassal N, Robson P, Andrew I. Are we using oxycodone appropriately? A utilisation review in a UK tertiary care centre. European Journal of Hospital Pharmacy 2013, 20(2), 125-128.
-
Authored Books
- Ashton M, Groundwater PW, Stocker S, Todd A. An Integrated Guide to Human Drug Metabolism: From Basic Chemical Transformations to Drug-Drug Interactions. Elsevier, 2024.
- Todd A, Groundwater PW, Gill JH. Anticancer Therapeutics: From Drug Discovery to Clinical Applications. Wiley-Blackwell, 2018.
-
Editorial
- Todd A, Ashiru-Oredope D. Building on the success of pharmaceutical public health: is it time to focus on health inequalities?. International Journal of Pharmacy Practice 2024, 32(5), 337-339.
-
Note
- Holmes HM, Todd A. Evidence-based deprescribing of statins in patients with advanced illness. JAMA Internal Medicine 2015, 175(5), 701-702.
-
Report
- Bambra C, Smith KE, Nwaru C, Bennett N, Albani V, Kingston A, Todd A, Matthews F. Targeting Health Inequalities: Realising the Potential of Targets in Reducing Health Inequalities. Newcastle upon Tyne: Health Equity North and The Health Foundation, 2023.
-
Reviews
- O'Neil H, Todd A, Pearce M, Husband A. What are the consequences of over and undertreatment of type 2 diabetes mellitus in a frail population? A systematic review. Endocrinology, Diabetes and Metabolism 2024, 7(2), e00470.
- Mosquera I, Todd A, Balaj M, Zhang L, BenitezMajano S, Mensah K, Eikemo TA, Basu P, Carvalho AL. Components and effectiveness of patient navigation programmes to increase participation to breast, cervical and colorectal cancer screening: A systematic review. Cancer Medicine 2023, 12(13), 14584-14611.
- Brown JVE, Walton N, Meader N, Todd A, Webster LAD, Steele R, Sampson SJ, Churchill R, McMillan D, Gilbody S, Ekers D. Pharmacy-based management for depression in adults. Cochrane Database of Systematic Reviews 2019, 2019(12), CD013299.
- Holmes HM, Todd A. The Role of Patient Preferences in Deprescribing. Clinics in Geriatric Medicine 2017, 33(2), 165-175.
- Rathbone AP, Todd A, Jamie K, Bonam M, Banks L, Husband AK. A systematic review and thematic synthesis of patients’ experience of medicines adherence. Research in Social and Administrative Pharmacy 2017, 13(3), 403-439.
- Alabi A, Todd A, Husband AK, Reilly JG. Safety profile of lamotrigine in overdose. Therapeutic Advances in Psychopharmacology 2016, 6(6), 369-381.
- Brown TJ, Todd A, O'Malley C, Moore HJ, Husband AK, Bambra C, Kasim A, Sniehotta FF, Steed L, Smith S, Nield L, Summerbell CD. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open 2016, 6(2), e009828.
- Husband AK, Todd A, Fulton J. Integrating science and practice in pharmacy curricula. American Journal of Pharmaceutical Education 2014, 78(3), 63.